Wall Street Journal is reporting on Friday’s page A9
that a clinical trial is being run at
the University of Toronto
to see if a component of “Fish Oil”,
the Omega-3 oil known by its initials EPA,
and sold in highly purified form
as the Amarin Inc. made prescription drug Vascepa,
can treat COVID-19 Virus
by reducing inflammation and protecting the inner layer of blood vessels known as the Endothelium.